Skip to main content

Table 3 ErgMS measurements and schedule

From: Ergothioneine supplementation in people with metabolic syndrome (ErgMS): protocol for a randomised, double-blind, placebo-controlled pilot study

Measurement Study visit
Baseline 6 wks 12 wks
Primary
 Recruitment    
 Completion    
 Supplementation compliance    
Secondary
 Platelet function    
 MDA    
 ALT    
 TNF-α    
 Nrf2    
 CRP    
 Fasting glucose    
 TAG    
 HDL-C    
 Weight    
 BMI    
 WC    
 Systolic BP    
 Diastolic BP    
  1. ALT Alanine transaminase, BMI Body mass index, BP Blood pressure, CRP C-reactive protein, HDL-C High-density lipoprotein-cholesterol, MDA Malondialdehyde, Nrf2 Nuclear factor erythroid 2-related factor 2, TAG Triacylglyceride, TNF-α Tumour necrosis factor-alpha, WC Waist circumference, wks Weeks
Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784